AbbVie Inc.·4

Dec 21, 5:29 PM ET

Durkin Brian L 4

4 · AbbVie Inc. · Filed Dec 21, 2021

Insider Transaction Report

Form 4
Period: 2021-12-20
Durkin Brian L
VP, Controller
Transactions
  • Exercise/Conversion

    Option (right to buy)

    2021-12-20$61.36/sh7,180$440,5650 total
    Exercise: $0.00From: 2018-02-16Exp: 2027-02-15Common Stock (7,180 underlying)
  • Sale

    Common Stock, $0.01 par value

    2021-12-20$128.51/sh11,790$1,515,13316,505 total
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2021-12-20$61.36/sh+7,180$440,56528,295 total
Footnotes (1)
  • [F1]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -